-
Mashup Score: 0Identification of genes that promote PI3K pathway activation and prostate tumour formation - 2 hour(s) ago
Oncogene – Identification of genes that promote PI3K pathway activation and prostate tumour formation
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 7
prostate cancer, PARP Inhibitor Therapy, Poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitors, PARP inhibitors, androgen receptor pathway inhibitor (ARPI), homologous recombination repair (HRR) genes, Olaparib plus Radium-223, Olaparib, Radium-223, Niraparib, abiraterone, enzalutamide, Talazoparib, Niraparib plus abiraterone, Talazoparib plus enzalutamide, COMRADE trial, BRCA1/2 alterations, KEYNOTE-365 study, Pembrolizumab, Durvalumab, avelumab, Bipolar Androgen Therapy (BAT), supraphysiologic testosterone (SPT), Cediranib, Olaparib plus Cediranib, Rad3-related protein (ATR) inhibitor, ceralasterib, TRAP trial, KEYLYNK-010 Trial, JAVELIN PARP Medley trial,
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0
Patient/provider trust, education and lifestyle choices are crucial as Black men face higher incidence and mortality in prostate cancer, experts said.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 0Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer - 16 hour(s) ago
This segment delves into targeting the androgen receptor pathway and conquering treatment resistance for potential breakthroughs in managing advanced prostate cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Unlocking Precision Care: Germline & Somatic Literacy in Prostate Cancer - Elisabeth Heath - 22 hour(s) ago
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Unlocking Precision Care: Germline & Somatic Literacy in Prostate Cancer – Elisabeth Heath Part of an Independent Medical Education Initiative Supported by LOXO@Lilly> Biographies: Elisabeth I. Heath, MD, FACP, Associate Center Director of Translational Sciences, Hartmann Endowed Chair for Prostate Cancer…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2
Dan George discusses the collaborative effort in managing PLUVICTO® therapy for prostate cancer with team members Kristen Davis and Sarah Wood. Dr. Davis describes the meticulous process of vetting patients for PLUVICTO® therapy, which includes reviewing patient information, scans, and coordinating with various departments for approval. Dr. Wood outlines her role in educating and managing…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Operationalizing and coordinating lutetium-177 PSMA treatment: roles of a multidisciplinary #ProstateCancer team. Kristen Davis, Sarah Yenser Wood, and @Daniel_J_George @DukeCancer underline the importance of a team approach and effective communication > https://t.co/sC6IxJAzNn https://t.co/Rzxf0yPPMl
-
-
Mashup Score: 0The Complex Interplay of Factors Driving Prostate Cancer Disparities - Steven Patierno - 1 day(s) ago
Steven Patierno delves into his 25-year journey tackling cancer disparities, with a focus on prostate cancer. Beginning in Washington D.C., Dr. Patierno’s work highlighted the stark impact of socioeconomic factors and healthcare access on cancer care. At Duke, he leads a comprehensive approach addressing the intricate mix of social inequities, healthcare access, and ancestry-related biology. He…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 17How to Report PSMA PET - Beyond the Abstract - 2 day(s) ago
methods to convey PSMA-PET/CT results, prostate cancer, Prostate-Specific Membrane Antigen (PSMA), PSMA PET, 177Lu-PSMA-SPECT, biochemical recurrence (BCR), PROMISE, PRIMARY, PSMA_RADS, E-PSMA.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2The Critical Intersection of Androgen Receptor Pathways and Cell Cycle Regulation in Prostate Cancer Therapy - Rana McKay - 2 day(s) ago
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Rana R. McKay, Medical Oncologist, Associate Professor, University of California, San Diego, San Diego, CA Alicia Morgans, MD, MPH , Genitourinary Medical Oncologist, Medical Director of Survivorship Program at…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Investigational Urine Test Better at Finding Prostate Cancer - 2 day(s) ago
MyProstateScore 2.0 (MPS2) proved more accurate at detecting prostate cancer than PSA and other biomarkers, researchers reported, sparing men more invasive testing, such as prostate biopsies and MRI (JAMA Oncol 2024 Apr 18). The test was designed to specifically identify higher-grade disease by measuring expression of 18 genes most often found in the presence of significant cancers. In 743 men with elevated PSA levels, using MPS2 would have avoided 35% to 42% of prostate biopsies without missing diagnoses of clinically significant disease, whereas existing biomarker testing could have avoided only 15% to 30% of biopsies. The improvement was more dramatic in men who previously had negative biopsies—the rate of unnecessary biopsies dropped to between 46% to 51% compared with 9% to 21% for existing tests. One limitation of the trial, however, was that only 13% of participants were African American, a population known to have a higher prevalence of prostate cancer.
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet
A functional in vivo screen from @ICR_London identified genes that promote #ProstateCancer and uncovered novel mechanisms of PI3K activation, further validated in patient prostate datasets. https://t.co/HUGD7Mfsri